.png)
Deep Pharma Intelligence Big Data Analytics Dashboard
The Deep Pharma Intelligence Big Data Analytics Dashboard highlights key metrics in AI for drug discovery, featuring 890 companies, 1,105 investors, and 2,150 funding rounds. The Funding Distribution chart shows a concentration of companies receiving under $5M, with fewer receiving over $500M.
890
Companies
1,105
Investors
2,150
Funding Rounds
670,750
Parameters
Deep Pharma Publicly Traded Companies Big Data Analytics Dashboard
Key Observations:
-
Dynamic Growth of Public Market: A bar chart shows significant growth in actual market performance since 2014, with projections for Q3-Q4 2021 at 21% of the total.
-
Top Companies by Market Capitalization: Johnson & Johnson leads with the highest capitalization, followed by Roche, Pfizer, and Moderna in 2021.
-
Cumulative Capitalization Dynamics: A line graph tracks steady growth in capitalization between January 2020 and June 2021, surpassing $4.5 trillion.
Diabetes Industry Global Dashboard
Key Highlights:
-
Top Metrics: 2,760 companies, 1,070 investors, 1,735 funding rounds, and 2,025 clinical trials are tracked, reflecting strong industry activity.
-
Funding Distribution: Most companies received funding under $50M, while a smaller number secured amounts exceeding $500M.
-
Company Distribution by Category: Categories include B2B services, Biotech, IT services, Manufacturing, R&D, and Service providers.
Diabetes Industry in Gulf Cooperation Council (GCC) Dashboard
Key Highlights:
-
Metrics Overview: The dashboard tracks 55 companies, 10 investors, 65 clinical trials, 20 funding rounds, and 45 R&D projects.
-
Funding Distribution: Most companies fall into funding categories of <$1M, $1M to $5M, and $50M to $100M.
-
Company Categories: Companies are divided into Biotech, IT Service, R&D, and Service sectors, with a fairly even
.png)
